BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pearson C, Siegel J, Gold JA. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. J Neurol Sci 2021;434:120096. [PMID: 34942586 DOI: 10.1016/j.jns.2021.120096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Munafò A, Arillotta D, Mannaioni G, Schifano F, Bernardini R, Cantarella G. Psilocybin for Depression: From Credibility to Feasibility, What's Missing? Pharmaceuticals (Basel) 2022;16. [PMID: 36678564 DOI: 10.3390/ph16010068] [Reference Citation Analysis]
2 Yu X. Six groups of poisonous mushrooms: classified according to clinical symptoms. HSET 2022;19:216-222. [DOI: 10.54097/hset.v19i.2853] [Reference Citation Analysis]
3 Huang J, Pham M, Panenka WJ, Honer WG, Barr AM. Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity. Front Psychiatry 2022;13:891512. [DOI: 10.3389/fpsyt.2022.891512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]